Serum ganglioside patterns in multiple sclerosis

Neurochem Res. 2001 Feb;26(2):95-100. doi: 10.1023/a:1011027125744.

Abstract

The relative distribution of gangliosides was determined in the serum of 37 patients with multiple sclerosis (MS) and of 30 healthy subjects. There was a significant increase of GM1 and GD1a, and a decrease of GM3 proportion in the serum of relapsing-remitting MS patients (RRMS) during their first MS attack. The RRMS patients in relapse with a long duration of the disease had a significant decrease of GM1 and an increase of GD1a portion in the serum. An increase of GD1a, one of the major brain neuron ganglioside fraction, suggested the neuron injury in the early and with a long duration RRMS. The finding of an increase of GM1, the main human myelin ganglioside, during the first MS attack in RRMS patients confirms previous evidence for the possible involvement of gangliosides in the early pathological course of demyelination in MS.

MeSH terms

  • G(M1) Ganglioside / blood
  • G(M3) Ganglioside / blood
  • Gangliosides / blood*
  • Humans
  • Multiple Sclerosis, Relapsing-Remitting / blood*
  • Reference Values

Substances

  • G(M3) Ganglioside
  • Gangliosides
  • ganglioside, GD1a
  • G(M1) Ganglioside